Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors.

被引：0
|
作者：
Coyne, Geraldine Helen O'Sullivan
Kummar, Shivaani
Khanh Tu Do
Holbeck, Susan
Hollingshead, Melinda G.
Horneffer, Yvonne
Juwara, Lamin
Srivastava, Apurva K.
Rubinstein, Larry
Piekarz, Richard
Sharon, Elad
Streicher, Howard
Conley, Barbara A.
Antony, Ramya
Collins, Jerry M.
Chen, Alice
Doroshow, James H.
机构：
[1] Early Clin Trials Dev Program, Bethesda, MD USA
[2] Stanford Univ, Sch Med, Phase Clin Res Program 1, Stanford, CA 94305 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA
[5] NCI, Div Canc Treatment & Diag, NIH, Frederick, MD 21701 USA
[6] NCI, Bethesda, MD 20892 USA
[7] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD USA
[8] Div Canc Treatment & Diag, Bethesda, MD USA
[9] NCI, Canc Therapy Evaluat Program, NIH, Bethesda, MD 20892 USA
[10] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA
[11] NCI, Rockville, MD USA
[12] Leidos Biomed Res Inc, Frederick, MD USA
[13] NCI, DCTD, Rockville, MD USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2614
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Phase 1 trial of bortezomib and clofarabine combination in adults with refractory solid tumors
    De Souza, Andre L.
    Takebe, Naoko
    Chen, Alice P.
    Doroshow, James H.
    Parchment, Ralph E.
    Srivastava, Apurva K.
    Rubistein, Lawrence
    Wilsker, Deborah
    Miller, Brandon L.
    Hogu, Murielle
    Coney, Geraldine O. Sullivan
    Kummar, Shivaani
    Govindharajulu, Jeevan
    Meehan, Robert
    Herrick, William G.
    Dull, Angie
    Ketchum, Donna
    Li, Shaowei
    Ji, Jiuping
    Piekarz, Richard
    CANCER RESEARCH, 2024, 84 (07)
  • [2] Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors, lymphomas, or myelodysplastic syndromes
    Khan, Sabrina S.
    O'Sullivan, Geraldine
    Rubinstein, Larry
    Kummar, Shivaani
    Juwara, Lamin
    Zlott, Jennifer
    Mittra, Arjun
    Hogu, Murielle
    Collins, Jerry
    Srivastava, Apurva
    Miller, Brandon
    Parchment, Ralph E.
    Hourigan, Christopher S.
    Pavletic, Steven
    Doroshow, James
    Chen, Alice P.
    Takebe, Naoko
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
  • [3] Phase I trial of the combination of bortezomib and clofarabine in adults with refractory solid tumors, lymphomas, or myelodysplastic syndromes.
    Nguyen, James Q.
    Coyne, Geraldine O'Sullivan
    Rubinstein, Larry
    Kummar, Shivaani
    Juwara, Lamin
    Zlott, Jennifer
    Naqash, Abdul Rafeh
    Hogu, Murielle
    Collins, Jerry
    Srivastava, Apurva
    Miller, Brandon
    Parchment, Ralph E.
    Meehan, Robert
    Hourigan, Christopher S.
    Pavletic, Steven
    Doroshow, James H.
    Chen, Alice P.
    Takebe, Naoko
    CANCER RESEARCH, 2021, 81 (13)
  • [4] A phase I study of vorinostat in combination with bortezomib in refractory solid tumors
    Ninan, J. A.
    Bailey, H.
    Kolesar, J.
    Marnocha, R.
    Eickhoff, J.
    Wright, J.
    Espinoza-Delgado, I.
    Alberti, D.
    Wilding, G.
    Schelman, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [5] A phase I study of vorinostat in combination with bortezomib in refractory solid tumors
    Schelman, W. R.
    Kolesar, J.
    Schell, K.
    Marnocha, R.
    Eickhoff, J.
    Alberti, D.
    Wilding, G.
    Bailey, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [6] Phase I/II trial of vorinostat in combination with etoposide in pediatric patients with relapsed/refractory solid tumors.
    Trippett, Tanya M.
    Smith, Amy
    Neville, Kathleen
    Chi, Susan
    Narendran, Aru
    Arceci, Robert
    Direnzo, Jennifer
    Gore, Lia
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [7] Phase I trial of bortezomib in combination with ocetaxel in patients with advanced solid tumors
    Messersmith, WA
    Baker, SD
    Lassiter, L
    Sullivan, RA
    Dinh, K
    Almuete, VI
    Wright, JJ
    Donehower, RC
    Carducci, MA
    Armstrong, DK
    CLINICAL CANCER RESEARCH, 2006, 12 (04) : 1270 - 1275
  • [8] Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial
    John Hayslip
    Uzair Chaudhary
    Mark Green
    Mario Meyer
    Steven Dunder
    Carol Sherman
    Shanta Salzer
    Andrew Kraft
    Alberto J Montero
    BMC Cancer, 7
  • [9] Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial
    Hayslip, John
    Chaudhary, Uzair
    Green, Mark
    Meyer, Mario
    Dunder, Steven
    Sherman, Carol
    Salzer, Shanta
    Kraft, Andrew
    Montero, Alberto J.
    BMC CANCER, 2007, 7 (1)
  • [10] A phase I trial of the combination of erlotinib and tipifarnib in patients with advanced solid tumors.
    Ma, CX
    Croghan, G
    Reid, J
    Hanson, L
    Mandrekar, S
    Marks, R
    Adjei, A
    Furth, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 192S - 192S
12345